Effect of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors on Lipoprotein(a) Levels: An Umbrella Review of Meta-analyses of Randomized Controlled Trials

Drugs 2026

View at publisher

Authors: Wenmei Qiao, Yunfei Feng, Zhifeng Wen, Lei Dou, Yongze Li

DOI: 10.1007/s40265-025-02274-x

Cited by: 5

References: 45

Fields of Study & Subjects

Lipoproteins and Cardiovascular Health Cerebrovascular and Carotid Artery Diseases Protease and Inhibitor Mechanisms

References 45